Physician profile
David A Beaird
NPI 1992760516
$5,171.26
in general payments reported to CMS, 2019-2025
43 companies · $1,448 in 2025
The $1,448 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $899 · 2020: $127 · 2021: $464 · 2022: $849 · 2023: $501 · 2024: $883 · 2025: $1,448.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,833.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,832.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $584.30 | 2019-2025 | Erleada, Carvykti, Rybrevant |
| C. R. Bard, INC. & Subsidiaries | $544.22 | 2019-2025 | Bard Urinary Drainage Bag, Purewick Female External Catheter |
| Astellas Pharma US INC | $430.16 | 2019-2025 | Myrbetriq, Xtandi |
| Boston Scientific Corporation | $380.55 | 2019-2025 | Spaceoar Vue System - 10ml, General - Female Sui, Rezum Generator |
| Healthtronics Stone Solutions, LLC | $370.14 | 2025 | Dornier Medtech, Dornier Medtech, Cvac Aspiration System |
| Abbvie INC. | $235.72 | 2019-2025 | |
| Procept Biorobotics Corporation | $235.31 | 2022-2025 | |
| Rochester Medical Corporation | $190.04 | 2019-2022 | |
| Urogen Pharma, INC. | $177.80 | 2023-2025 | Jelmyto |
| Neotract INC. | $176.21 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $147.28 | 2019-2025 | |
| Sumitomo Pharma America, INC. | $135.89 | 2023-2025 | Gemtesa, Orgovyx |
| Accord Healthcare, INC. | $129.48 | 2023-2024 | |
| Tolmar, INC. | $119.20 | 2023-2025 | Jatenzo, Eligard |
| Olympus America INC. | $116.19 | 2019-2025 | Itind System, Uretero-Reno Fiberscope, Hd Camera Head |
Show all 43 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tolmar Pharmaceuticals, INC. | $88.88 | 2019-2022 | |
| Ferring Pharmaceuticals INC. | $88.23 | 2019-2025 | Adstiladrin |
| Dendreon Pharmaceuticals LLC | $87.13 | 2019-2024 | Provenge |
| Axonics, INC. | $86.23 | 2020-2024 | Bulkamid, Axonics |
| Antares Pharma, INC. | $85.35 | 2019-2022 | |
| Urovant Sciences INC | $79.11 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $61.97 | 2021-2023 | Lynparza, Keytruda |
| E.R. Squibb & Sons, L.L.C. | $53.60 | 2022-2023 | Opdivo |
| Laborie Medical Technologies Corp. | $45.86 | 2024-2025 | Optilume Bph Drug Coated Balloon Catheter |
| Agiliti Surgical, INC. | $43.43 | 2023-2025 | Sonablate, Trinity, Boston Scientific Lumenis Pulse 120h Holmium Laser W/ Moses Technology |
| Verity Pharmaceuticals INC. | $38.34 | 2024 | Trelstar |
| Intuitive Surgical, INC. | $37.95 | 2019 | |
| Pfizer INC. | $37.11 | 2025 | |
| Myovant Sciences INC. | $36.67 | 2022 | |
| Blue Earth Diagnostics | $35.75 | 2019-2022 | |
| Coloplast Corp | $31.96 | 2020-2025 | |
| Amgen INC. | $29.22 | 2022 | |
| Ambu INC. | $28.42 | 2020-2024 | |
| Zyla Life Sciences, INC. | $27.03 | 2019 | |
| Halozyme INC | $25.68 | 2023 | |
| Endo Pharmaceuticals INC. | $23.59 | 2019 | |
| Photocure INC | $23.43 | 2024 | Cysview |
| Telix Pharmaceuticals | $22.06 | 2025 | Illuccix |
| Myriad Genetic Laboratories, INC. | $21.19 | 2025 | Prolaris |
| Smith+Nephew, INC. | $18.13 | 2019 | |
| Teleflex LLC | $17.62 | 2023 | Urolift |
| Medtronic, INC. | $13.01 | 2021 | |
| Sun Pharmaceutical Industries INC. | $11.82 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Beaird listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.